Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution

Tuesday, November 09, 2021

Azurity Pharmaceuticals Inc a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions today announced the US Food and Drug Administration FDA approval of EPRO...

FDA Grants Profounda Orphan Drug Designation Approval for treatment of Treatment of Invasive Candidiasis with Miltefosine

Tuesday, November 09, 2021

Profounda Inc announced that it has received the US Food and Drug Administrations Orphan Drug Designation Approval for the use of miltefosine to treat Invasive Candidiasis with Miltefosine Profounda licensed miltefosine Impavido from Knight Therapeut...

Green Circle Life Launches Covid-19 Vaccination Mandate Compliance Solution

Friday, November 05, 2021

Green Circle Life provider of an allinone communication and engagement platform SmartFHR has launched the Covid Passport their endtoend solution to help employers comply with an upcoming Covid vaccination mandate from the Occupational Safety and Heal...

Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke

Friday, November 05, 2021

ACTICOR BIOTECH a clinical stage biotechnology company involved in the acute phase of thrombotic diseases today announces that the US Food and Drug Administration FDA has provided clearance for the initiation of a clinical trial in US with glenzocima...

Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics

Wednesday, November 03, 2021

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and Metagenomi Inc a genetic medicines company with a versatile portfolio of nextgeneration gene editing tools today announced that the two companies have ent...

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology

Wednesday, November 03, 2021

Yokogawa Electric Corporation announces that it has acquired all shares of Insilico Biotechnology AG Insilico a Stuttgart Germanybased developer and provider of bioprocess software and services Fostering the development of the bioeconomy is one of th...

Venatorx Pharmaceuticals Announces Collaboration with Roche to Develop New Class of Antibiotics targeting WHO Critical Priority Pathogen

Tuesday, November 02, 2021

Venatorx Pharmaceuticals announced today that it has entered into a Research Collaboration and License Agreement with Roche to discover characterize and develop new small molecule inhibitors of the Penicillin Binding Proteins PBPs in Gramnegative bac...

AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences

Tuesday, November 02, 2021

AlivaMab Discovery Services ADS a leader in the discovery of superior antibody therapeutics announced an expanded agreement with IGM Biosciences IGM ADS will rapidly discover diverse panels of human antibodies for the development of engineered antibo...

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

Monday, November 01, 2021

WuXi Biologics a global company with leading openaccess biologics technology platforms announced it has successfully launched the GMP operation of its new drug product facility located in Wuxi China which is the eighth operational drug product facili...

Ubiquigent Extends And Expands Drug Discovery Collaboration With Bristol Myers Squibb

Friday, October 29, 2021

Ubiquigent Limited announces the extension and expansion of its longterm collaboration with Bristol Myers Squibb Under the terms of the agreement Ubiquigent will provide Bristol Myers Squibb with increased access to its deubiquitylase DUB enzyme inhi...